These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21701001)

  • 21. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative, functional and oncological outcomes after open and minimally invasive prostate cancer surgery: experience from Australasia.
    Cathcart P; Murphy DG; Moon D; Costello AJ; Frydenberg M
    BJU Int; 2011 Apr; 107 Suppl 3():11-9. PubMed ID: 21492370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination.
    Djavan B; Zlotta AR; Susani M; Heinz G; Shariat S; Silverman DE; Schulman CC; Marberger M
    Urology; 1997 Dec; 50(6):986-92; discussion 992-3. PubMed ID: 9426739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
    Hara N
    Eur Urol; 2008 Sep; 54(3):598-9. PubMed ID: 18226440
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
    Fütterer JJ; Barentsz JO
    Eur Urol; 2008 Sep; 54(3):599-600. PubMed ID: 18226439
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy.
    Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P
    BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: a multi-reader study.
    Rosenkrantz AB; Mussi TC; Hindman N; Lim RP; Kong MX; Babb JS; Melamed J; Taneja SS
    Clin Radiol; 2012 Dec; 67(12):e83-90. PubMed ID: 22981729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of MRI in follow-up after focal therapy for prostate carcinoma.
    De Visschere PJ; De Meerleer GO; Fütterer JJ; Villeirs GM
    AJR Am J Roentgenol; 2010 Jun; 194(6):1427-33. PubMed ID: 20489080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.
    Yakar D; Debats OA; Bomers JG; Schouten MG; Vos PC; van Lin E; Fütterer JJ; Barentsz JO
    J Magn Reson Imaging; 2012 Jan; 35(1):20-31. PubMed ID: 22174000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to select the right patients for focal therapy of prostate cancer?
    Passoni NM; Polascik TJ
    Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
    Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
    Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
    Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
    J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy.
    Leibovici D; Chiong E; Pisters LL; Guo CC; Ward JF; Andino L; Prokhorova IN; Troncoso P
    J Urol; 2012 Jul; 188(1):98-102. PubMed ID: 22578724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryosurgical ablation of the prostate: current technique and clinical outcomes.
    Long JP
    Surg Technol Int; 2003; 11():213-9. PubMed ID: 12931304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance.
    Villers A; Lemaitre L; Haffner J; Puech P
    Curr Opin Urol; 2009 May; 19(3):274-82. PubMed ID: 19325494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up.
    Menon M; Bhandari M; Gupta N; Lane Z; Peabody JO; Rogers CG; Sammon J; Siddiqui SA; Diaz M
    Eur Urol; 2010 Dec; 58(6):838-46. PubMed ID: 20869162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.